Top compounds associated with response to NR2C1


Feature Type Standardized
Nominal ANOVA
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA clofarabine CTRPv2 pan-cancer AAC 0.095 0.001
mRNA OSI-027 GDSC1000 pan-cancer AAC 0.1 0.001
mRNA GSK429286A GDSC1000 pan-cancer AAC 0.11 0.001
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.002
mRNA JQ12 GDSC1000 pan-cancer AAC 0.11 0.002
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA QL-XII-47 GDSC1000 pan-cancer AAC 0.1 0.002
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.002
mRNA blebbistatin CTRPv2 pan-cancer AAC -0.23 0.002
Download CSV